Centrus Energy Drops 18% From May Peak as Earnings Miss Overshadows Enrichment Contract Win

Centrus Energy shares closed at $169.00 on May 20, down 2.3% on the day and 18% below where they traded in early May, after the nuclear fuel supplier's first-quarter results fell well short of analyst forecasts. Diluted earnings per share came in at $0.45, against $1.60 a year earlier — a 63% decline — on revenue of $76.7 million. Net income dropped to $10.0 million as expansion-related costs climbed. The miss matters because Centrus is carrying a 55x trailing earnings multiple that prices in a multi-year build-out of U.S. uranium enrichment capacity. Any sign that execution is slipping or costs are running ahead of schedule hits the stock hard. Northland Securities cut its Q4 2026 EPS estimate from $0.77 to $0.67 following the report. Needham trimmed its price target while maintaining a buy rating. The operational story is not falling apart — the company raised full-year 2026 revenue guidance to $450-$500 million and holds a $900 million-plus HALEU enrichment contract from the Department of Energy — but near-term profitability is clearly compressing. On April 22, Centrus announced it had selected Geiger Brothers as construction contractor for the Piketon, Ohio enrichment facility expansion, which will boost output of both standard low-enriched uranium and High-Assay Low-Enriched Uranium for advanced reactors. Shares jumped 8.7% to $208.10 on that news. The rally lasted days before the earnings release reversed it. Uranium spot prices add another headwind. Spot uranium edged down to $85.95 per pound in early May, pulling back from January highs above $100. The correction looks driven by profit-taking near the $95-$100 resistance zone rather than any demand deterioration, but it has dragged uranium equities broadly. Centrus derives most of its revenue from enrichment services priced in Separative Work Units rather than raw uranium, yet with 88 daily moves exceeding 5% over the past year, the stock trades as a high-beta proxy for nuclear fuel sentiment regardless. The balance sheet gives little room for slippage. Centrus carries a 152% debt-to-equity ratio and negative levered free cash flow of $10.88 million. The company ended 2025 with roughly $2 billion in unrestricted cash and plans to spend $350-$500 million on capital expenditures this year, almost all of it for Piketon. If construction timelines stretch or DOE disbursements are delayed, the cushion shrinks quickly. The stock is already 63% below its 52-week high of $464.25, set in October 2025. Technically, LEU broke below both its short- and long-term moving averages in early May. A close below $166.47 would deepen the sell signal. Second-quarter results, due in early August, are the next hard test of whether Centrus can deliver on its raised revenue guidance while absorbing higher construction costs. Piketon timeline updates and any new DOE HALEU contract awards will move the stock before then. On the commodity side, a sustained move back above $90 per pound in spot uranium would likely provide a floor for LEU; further weakness toward $80 would accelerate the current slide.